Navigation Links
Synvista Therapeutics to Develop Topical Formulation of ALT-2074 for the Treatment of Psoriasis
Date:1/17/2008

MONTVALE, N.J., Jan. 17 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (Amex: SYI) today announced the signing of an agreement with privately- held Novel Therapeutic Technologies, Inc. to provide Synvista with formulation work for a topical cream formulation of ALT-2074 for the treatment of psoriasis. ALT-2074 is one of the Company's lead compounds under development for use in cardiovascular disease.

"We believe that ALT-2074 is a logical choice for a potential therapy in mild-to-moderate plaque psoriasis. TNF-alpha is an established target for drug development in psoriasis and other autoimmune diseases. The effectiveness of approved TNF antagonists may relate to their demonstrated ability to inhibit the induction of cell adhesion molecules and consequent migration of pro-inflammatory cells into inflamed tissue," said Noah Berkowitz, M.D., Ph.D., President and Chief Executive Officer of Synvista Therapeutics. "ALT-2074 can block TNF-alpha activated expression of cell adhesion molecules, I-CAM and V-CAM, which may be essential for cellular migration. As such, we believe that a topical formulation of ALT-2074 may be a promising therapy for mild-to-moderate plaque psoriasis, without the side effects associated with systemic treatment using anti-TNF biologics."

"We have identified sites in Israel to perform a planned Phase 2 clinical trial for plaque psoriasis beginning mid-2008, pending approval from the Ministry of Health in Israel," added Dr. Berkowitz. "The Ministry of Health is already familiar with ALT-2074 since it approved its use in our ongoing Study 203. Based on our current timeline, assuming timely receipt of regulatory approval, we hope to announce study results in the fourth quarter of 2008. We expect this ps
'/>"/>

SOURCE Synvista Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Synvista Therapeutics to be Featured on Wallst.net
2. Synvista Therapeutics to Present at the BIO InvestorForum 2007
3. Cell Therapeutics, Inc. (CTI) Prices $1.27 million (euros 856.000) Offering of Common Stock through Societe Generale
4. Protalix BioTherapeutics Signs Lease Agreement for Expansion of its Manufacturing and Research Facility in Carmiel, Israel
5. Cell Therapeutics, Inc. Announces Authorization to Publish Italian Listing Prospectus
6. Mersana Therapeutics Appoints C. Boyd Clarke Chairman of the Board of Directors
7. Nektar Therapeutics President and CEO Howard W. Robin to Present At JPMorgan 26th Annual Healthcare Conference
8. Cell Therapeutics, Inc. (CTI) Hosts Conference Call to Discuss Update on Zevalin(R) Acquisition, CMS Reimbursement, and PIX301 Timeline
9. Sirnaomics Received Multiple Government Fundings For Its Multi-Targeted siRNA Therapeutics Programs
10. Co-Inventor of Amgens Aranesp(R) Technology Directs Worldwide Patent Strategy for Diffusion Pharmaceuticals First-in-Class Oxygen Enhancing Therapeutics
11. Pearl Therapeutics, Inc. Expands Its Senior Management Team With Top Talent in Clinical Development and Regulatory Affairs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ublication of a study led by Yuntao Wu, assistant ...of Molecular and Microbiology, the medical communi...an immunodeficiency virus (HIV) attacks cells in t...fected more than 33 million people worldwide in 20...cs. , In the Sept. 5 issue of the journal Cell ...
(Date:9/5/2008)...s much of a hold on the human imagination, or on h...popular uses money, medals, jewelry and more gol...980s, when Masatake Haruta and Graham Hutchings in...een considered inactive, could be an extraordinari...erature oxidation of CO and Hutchings the hydrochl...
(Date:9/5/2008).... 5 /- Men living in Western,Oregon w...arged prostate,now have the option of out-patient,..., Inc. is pleased to announce that a network of do...hrough LIFE(TM) (Laser Induced,Flow Enhancement) l...H),that quickly and gently eliminates swollen pros...
(Date:9/5/2008)...ry Strategy for Belinostat in PTCL, COPENHAGEN, D...Target,A/S (OMX: TOPO) announced that a positive r...ol Assessment (SPA) for a phase III trial for beli... pivotal trial is to enrol,approximately 120 patie...,designation was granted for the development of be...
Breaking Biology Technology:Researchers decode viral process that prepares cells for HIV infection 2Scientists peel away the mystery behind gold's catalytic prowess 2Scientists peel away the mystery behind gold's catalytic prowess 3Scientists peel away the mystery behind gold's catalytic prowess 4Revolutionary New In-Office EVOLVE(R) Laser Prostate Treatment Available Throughout Western Oregon 2Positive SPA Reply From the FDA for TopoTarget's Pivotal Trial With Belinostat in PTCL 2Positive SPA Reply From the FDA for TopoTarget's Pivotal Trial With Belinostat in PTCL 3Positive SPA Reply From the FDA for TopoTarget's Pivotal Trial With Belinostat in PTCL 4Positive SPA Reply From the FDA for TopoTarget's Pivotal Trial With Belinostat in PTCL 5
...out more than just doing the usual lessons away fr...her, technology is a medium that opens up whole ne..., and what the relationship should be between teac...age, a research associate at MIT Media Lab and co-...sed the recent Distance Teaching and Learning Conf...
...slowing the flow of news in the technology busines...nificant product announcements. , ,Macromedia anno...s development suite for web developers and designe...roducts including Dreamweaver, Flash Professional,...ease of Studio 8 offers several improvements drive...
...al technology subsidiary of Marshall & Ilsley Corp...e, of Herndon, Va.-based TREEV, LLC, a provider ...he financial industry. The company delivers browse... both lending and deposit environments. TREEV will...ns (AFS), a Metavante company. , ,"The acquisition...
...day announced the promotions of Dr. Frank Burgaezy...ice presidents, responsible for leading all aspect...he Madison headquarters of Bruker AXS, now leads t...D) business, and as chief technology officer heads...any, now leads the Bruker AXS X-ray diffraction (X...
Other Biology Technology:Schrage: Don't think of distance learning as just automation 2Schrage: Don't think of distance learning as just automation 3Hot products launch in summer's slow days 2Hot products launch in summer's slow days 3
(Date:9/4/2008)...Even scientists define ,a gene, in different ways,...o have various ways of framing the concept of a ge...ber 2008 issue of EMBO reports . , The study, Fr...icles in British and Norwegian newspapers: The Gua... Aftenposten, Dagbladet, and VG from Norway. , T...
(Date:9/4/2008)...the anniversary of the September 11 attacks approa...ed a new podcast describing an array of technologi...urity. The podcast is the sixth episode in ACS,s ...series. , With new episodes posted twice monthly...ing society in the 21st Century, and explains how ...
(Date:9/4/2008)...abilize the tuna population? Can we compute how to...ood production? , Those and other questions will...aticians, economists, biologists and environmental...ew Institute for Computational Sustainability, bei...onal Science Foundation (NSF). This program is des...
(Date:9/4/2008)...8 Declaring the success of an unprecedented exper...ed philanthropists Eli and Edythe Broad announced ... the Broad Institute of Harvard and MIT to $600 mi...0 million, the Broads today gave an endowment of $...en launched as a 10-year "venture" experiment, int...
Breaking Biology News(10 mins):What is a gene? 2New 'chemical radar' among national security innovations in ACS podcast 2New 'chemical radar' among national security innovations in ACS podcast 3Cornell gets $10 million NSF grant to establish new sustainability institute 2Eli and Edythe L. Broad make unprecedented gift to endow Broad Institute of Harvard & MIT 2Eli and Edythe L. Broad make unprecedented gift to endow Broad Institute of Harvard & MIT 3Eli and Edythe L. Broad make unprecedented gift to endow Broad Institute of Harvard & MIT 4Eli and Edythe L. Broad make unprecedented gift to endow Broad Institute of Harvard & MIT 5ACM Taps Two Senior Leaders to Head Up New Strategic Initiatives 19970 1ACM Taps Two Senior Leaders to Head Up New Strategic Initiatives 19970 2Romark Laboratories Completes Enrollment in U S Phase II Study of Nitazoxanide for Chronic Hepatitis C Genotype 1 Non Responders 2156 1Romark Laboratories Completes Enrollment in U S Phase II Study of Nitazoxanide for Chronic Hepatitis C Genotype 1 Non Responders 2156 2Romark Laboratories Completes Enrollment in U S Phase II Study of Nitazoxanide for Chronic Hepatitis C Genotype 1 Non Responders 2156 3Iraq war service 3A A risk factor for bronchiolitis 3F 19967 1Iraq war service 3A A risk factor for bronchiolitis 3F 19967 2Figure Skater Peggy Fleming Teams With HealthSaver 3A Fit for Summer 19965 1Figure Skater Peggy Fleming Teams With HealthSaver 3A Fit for Summer 19965 2Figure Skater Peggy Fleming Teams With HealthSaver 3A Fit for Summer 19965 3Figure Skater Peggy Fleming Teams With HealthSaver 3A Fit for Summer 19965 4Figure Skater Peggy Fleming Teams With HealthSaver 3A Fit for Summer 19965 5
...ers at Yale have brought to light a mechanism that...i apparatus, duplicates as cells prepare to divide...ham Warren , professor of cell biology , and his ...arasite that causes Sleeping Sickness. Like many p...only one of each internal organelle, making it ide...
... the Amazon tropical forests are old. Really old, ...erican and Brazilian researchers studying tree gro...g radiocarbon dating methods, the team, which incl...half of all trees greater than 10 centimeters in d...rees, Trumbore said, are as much as 750 to 1,000 y...
...ents with seasonal affective disorder (SAD), start...ring the fall can reduce the risk of developing de...ports a study in the Oct. 15 issue of Biological P...ogical Psychiatry, published by Elsevier, a world-... are the first systematic studies that indicate th...
... news is that medical advances in perinatal care h... The bad news is they,re often at risk of developi...ase caused by having to place the tiny infants on ...iratory failure. , It,s really a win-lose situatio...h dramatically underdeveloped lungs--forcing them ...
Other Biology News:Sleeping sickness parasite shows how cells divide their insides 2Amazon trees much older than assumed, raising questions on global climate impact of region 2In SAD patients, autumn antidepressants can prevent winter depression 2Group proves it's possible to grow new lung alveoli by growing new blood vessels 2
ID clarifier: With ethidium bromide (50 μg/ml)
Extremely high efficiency packaging extracts useful for transfecting our EpiFOS™ or CopyControl™ Fosmids, or any DNA vector with cos sites. A tremendous value when conpared to the competition
RNA Sample Buffer is a convenient, premixed, formamide-containing sample buffer for experimental samples and Perfect RNA Markers. This 2X sample buffer needs no dilution and is suitable for native an
...se RAW 264. 7 cells were cultured in DMEM with 4 m...e of growth. In order to keep the antigens in the...nol. The cells are arrayed on a 12-well (5 mm) ad...fically treated to enhance cellular attachment and...
Biology Products: